Skip to main content
. 2016 Oct 24;7(46):76250–76260. doi: 10.18632/oncotarget.12841

Table 3. MiRNA expression by qRT-PCR in non-recurrent and recurrent patients.

MiRNA Non-recurrent, n=57 Recurrent,a n=27 Fold changeb P valuec P valued
hsa-miR-4732-5p 10.40±3.92 8.60±3.45 1.80 0.144 0.044
hsa-miR-451a 4.79±4.31 3.90±3.03 0.89 0.569 0.336
hsa-miR-3200-3p 22.50±7.10 22.92±10.11 −0.42 0.882 0.845
hsa-miR-3143 32.57±6.71 34.34±4.63 −1.78 0.524 0.217
hsa-miR-485-3p 12.80±4.02 11.04±7.80 1.76 0.129 0.276
hsa-miR-4772-3p 19.71±5.52 25.62±8.71 -5.91 0.002 0.002
hsa-miR-1255b-5p 8.09±3.38 8.42±3.68 −0.33 0.966 0.686
hsa-miR-1180-3p 13.02±6.14 13.12±7.49 −0.10 0.629 0.950
hsa-miR-451b 22.84±6.51 25.80±7.84 -2.95 0.093 0.074
hsa-miR-3200-5p 13.65±3.80 14.22±2.69 −0.58 0.248 0.480
a

Relative expression presented as mean ± standard deviation of ΔCT.

b

Fold difference (2−ΔΔCT) between the non-recurrent and recurrent groups. A negative value indicates under-expression, and a positive value indicates over-expression in the recurrent group.

c

Non-parametric Mann-Whitney U-tests.

d

Student's t test.